Cardiff Oncology(DE:XE7C)
€0.66-0.04 (-1.93%)
DE:XE7C
Cardiff Oncology Revenue
€0.66
At close:-0.04 (-1.93%)
Cardiff Oncology (XE7C) Revenue
3 Followers
Cardiff Oncology Revenue
Cardiff Oncology had a revenue of 104.00K in the quarter ending Jun 30, 2026, with 153.66%. This bring the company's revenue in the last twelve months to 508.00K, Decreased 3.24%. In the fiscal year ending Dec 31, 2025, Cardiff Oncology had annual revenue of 593.00K with -13.18% growth.
- Revenue (ttm)
- 508.00K
- Revenue Growth
- -13.17%
- P/S Ratio
- 93.97
- Revenue/Employee
- EUR 19,129
- Employees
- 31
- Market Cap
- EUR 55.72M
Revenue Chart
Cardiff Oncology Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 593.00K | -90.00K | -13.18% |
| Dec 31, 2024 | 683.00K | 195.00K | 39.96% |
| Dec 31, 2023 | 488.00K | 102.00K | 26.42% |
| Dec 31, 2022 | 386.00K | 27.00K | 7.52% |
| Dec 31, 2021 | 359.00K | -7.00K | -1.91% |
| Dec 31, 2020 | 366.00K | 121.37K | 49.61% |
| Dec 31, 2019 | 244.63K | -133.37K | -35.28% |
| Dec 31, 2018 | 378.00K | -127.00K | -25.15% |
| Dec 31, 2017 | 505.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.